Lorazepam is not an antipsychotic. It belongs to a completely different class of medications called benzodiazepines. While lorazepam is sometimes used alongside antipsychotics in psychiatric settings, the two drug classes work through different mechanisms, treat different symptoms, and carry different risks.
What Lorazepam Actually Is
Lorazepam is a benzodiazepine, the same drug class as diazepam (Valium) and alprazolam (Xanax). Its FDA-approved uses include short-term relief of anxiety symptoms, anxiety-related insomnia, sedation before anesthesia, and treatment of status epilepticus (a type of prolonged seizure). None of its approved uses involve treating psychosis, hallucinations, or delusions.
How the Two Drug Classes Work Differently
The core difference comes down to which chemical messenger each drug targets in the brain. Lorazepam enhances the activity of GABA, the brain’s primary calming signal. It binds to a spot on the GABA-A receptor that’s separate from where GABA itself attaches, nudging the receptor into a more active state. The result is sedation, reduced anxiety, and muscle relaxation.
Antipsychotics target dopamine. First-generation (typical) antipsychotics like haloperidol block dopamine D2 receptors, and they work best when they block roughly 72% of those receptors in the brain. Second-generation (atypical) antipsychotics like olanzapine and risperidone block both dopamine and serotonin receptors. This dopamine blockade is what reduces hallucinations, delusions, and disordered thinking, symptoms that lorazepam simply doesn’t address on its own.
Why Lorazepam Shows Up in Psychiatric Care
The confusion is understandable. Lorazepam is commonly used in psychiatric hospitals and emergency departments, often right alongside antipsychotics. But it plays a supporting role rather than treating psychosis directly.
In acute agitation, regardless of the cause, lorazepam is frequently chosen as a sedative because of its rapid onset. When given intravenously, it begins working within one to three minutes. Clinical studies have found that combining lorazepam with haloperidol (an antipsychotic) is more effective at calming severely agitated patients than either drug alone. In these situations, the antipsychotic addresses the psychotic symptoms while lorazepam provides fast-acting sedation and anxiety relief.
Lorazepam also has a specific, somewhat surprising role in catatonia, a condition where a person becomes unresponsive, rigid, or unable to move. Benzodiazepines are actually the first-choice treatment for catatonia regardless of the underlying cause. This works because catatonia involves impaired GABA signaling in the brain, which lorazepam directly corrects. Doctors even use a “lorazepam challenge test” as a diagnostic tool: if a dose of lorazepam temporarily resolves the catatonia, it confirms the diagnosis.
The American Psychiatric Association’s schizophrenia treatment guidelines also mention benzodiazepines as an option for managing akathisia, a restless, uncomfortable side effect caused by antipsychotic medications themselves. In that case, lorazepam treats the side effect of the antipsychotic rather than the psychotic illness.
Different Side Effect Profiles
The two drug classes carry meaningfully different risks, which is another reason the distinction matters.
Antipsychotics are well known for causing movement-related side effects called extrapyramidal symptoms: involuntary muscle contractions, tremors, restlessness, and in long-term use, a condition called tardive dyskinesia where repetitive movements become permanent. In clinical comparisons, haloperidol alone caused these movement problems in 16% to 20% of patients. Lorazepam caused them in just 3%.
Lorazepam’s primary safety concern is respiratory depression, where breathing slows dangerously. In one randomized trial comparing sedation options, lorazepam caused respiratory depression in 48% of patients, the highest rate among the drugs tested. This risk is why benzodiazepines require close monitoring, especially when given by injection.
The other major risk with lorazepam is physical dependence. Benzodiazepines can create tolerance and withdrawal symptoms relatively quickly, which is why lorazepam is approved only for short-term use (up to four months for anxiety). Antipsychotics don’t carry the same dependence risk, though they have their own long-term concerns including metabolic changes like weight gain and elevated blood sugar.
Can Lorazepam Treat Hallucinations?
On its own, lorazepam is not considered effective against hallucinations or delusions. There is limited case-level evidence of lorazepam being used as an add-on to antipsychotic therapy for auditory hallucinations in schizophrenia, but this reflects its role as an adjunct, not a standalone treatment. If you’re experiencing psychotic symptoms, benzodiazepines alone would not be the appropriate treatment. Antipsychotic medications remain the primary pharmacological approach for those symptoms because they directly address the dopamine signaling that drives them.